UA102081C2 - Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства - Google Patents

Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства

Info

Publication number
UA102081C2
UA102081C2 UAA201007218A UAA201007218A UA102081C2 UA 102081 C2 UA102081 C2 UA 102081C2 UA A201007218 A UAA201007218 A UA A201007218A UA A201007218 A UAA201007218 A UA A201007218A UA 102081 C2 UA102081 C2 UA 102081C2
Authority
UA
Ukraine
Prior art keywords
prophylaxis
treatment
lyme disease
veterinary use
manufacture
Prior art date
Application number
UAA201007218A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Владимир ВРЗАЛ
Либор БИТТНЕР
Иржи НЕПЕРЕНИ
Йосеф ХУМЕЛА
Original Assignee
Байовета, А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байовета, А.С. filed Critical Байовета, А.С.
Publication of UA102081C2 publication Critical patent/UA102081C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
UAA201007218A 2007-11-14 2008-10-21 Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства UA102081C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20070791A CZ301244B6 (cs) 2007-11-14 2007-11-14 Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
PCT/CZ2008/000130 WO2009062454A2 (fr) 2007-11-14 2008-10-21 Vaccin universel pour le traitement et la prophylaxie de la maladie de lyme à une usage humain et vétérinaire et son procédé de fabrication

Publications (1)

Publication Number Publication Date
UA102081C2 true UA102081C2 (ru) 2013-06-10

Family

ID=40600158

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201007218A UA102081C2 (ru) 2007-11-14 2008-10-21 Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства

Country Status (5)

Country Link
EP (1) EP2219670A2 (fr)
CZ (1) CZ301244B6 (fr)
RU (1) RU2472525C2 (fr)
UA (1) UA102081C2 (fr)
WO (1) WO2009062454A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
CZ301548B6 (cs) * 2008-08-20 2010-04-14 Bittner@Libor Univerzální preparát ke zvýšení obranyschopnosti, prevenci, profylaxi a lécbe Lymeské boreliózy pro humánní a veterinární použití, zpusob jeho výroby a použití
PL223175B1 (pl) 2012-10-22 2016-10-31 Inst Chemii Bioorganicznej Polskiej Akademii Nauk Szczepionka przeciw boreliozie, konstrukt genetyczny, rekombinowane białko, sposób otrzymywania konstruktu genetycznego, sposób otrzymywania szczepionki, sposób otrzymywania rekombinowanych białek, zastosowanie rekombinowanych białek do wytwarzania szczepionki przeciwko boreliozie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872550B1 (en) * 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
RU2102081C1 (ru) * 1991-07-11 1998-01-20 Иммуно АГ Иммуногенная композиция против боррелиоза лайма, способ иммунизации млекопитающего против боррелиоза лайма, способ получения белка pc borrelia burgdorferi, диагностический агент для обнаружения b.burgdorferi и способ обнаружения антител к b.burgdorferi
SK279968B6 (sk) * 1993-04-29 1999-06-11 Immuno Aktiengesellschaft Imunogénny prostriedok, sekvencia rekombinantnej d
US7008625B2 (en) * 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
EP0757556B1 (fr) * 1994-04-11 2006-06-14 Wyeth Holdings Corporation Bacterine de borrelia burgdorferi
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
NZ576564A (en) * 2006-11-03 2012-03-30 Schering Plough Ltd Canine lyme disease vaccine
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby

Also Published As

Publication number Publication date
CZ301244B6 (cs) 2009-12-16
WO2009062454A3 (fr) 2009-07-16
EP2219670A2 (fr) 2010-08-25
RU2472525C2 (ru) 2013-01-20
CZ2007791A3 (cs) 2009-05-27
WO2009062454A2 (fr) 2009-05-22
RU2010123897A (ru) 2011-12-20

Similar Documents

Publication Publication Date Title
WO2008124647A3 (fr) Compositions immunogènes comportant des polypeptides de mycobacterium tuberculosis et des fusions de ceux-ci
SG160329A1 (en) Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
SG158145A1 (en) Vaccines against chlamydial infection
DE69941454D1 (de) Impfstoff gegen staphylokokken-vergiftung
WO2008143747A3 (fr) Procédés et appareil permettant d'utiliser des groupes de tranches pour le décodage d'informations de codage vidéo multivues (mvc)
MX2010004482A (es) Anticuerpos anti-proteina g vsr.
EP4245320A3 (fr) Méthodes et compositions pour une protection immunitaire contre e. coli pathogène extra-intestinale
EA200870129A1 (ru) Человеческие антитела против il-23, композиции, способы и применение
WO2007092496A3 (fr) 7,9-dihydro-purin-8-one et analogues associés utilisés en tant qu'inhibiteurs de hsp90
ME00982B (me) Oslabljeni sojevi bakterije mycoplasma gallisepticum
WO2016115310A3 (fr) Dispositif pour loger un outil chirurgical avant et pendant des procédures médicales
WO2012135701A3 (fr) Compositions et procédés pour la détection d'anaplasma platys
WO2009077577A3 (fr) Antigènes de vaccin provenant de la piscirickettsia salmonis
UA102081C2 (ru) Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства
WO2016118766A8 (fr) Procédés et systèmes de rmn pour la détection rapide de pathogènes transmis par les tiques
MX370869B (es) Abrazaderas gemelas.
EP4137506A4 (fr) Composition de vaccin contre la peste porcine africaine
AU2001281145A1 (en) Recombinant constructs of borrelia burgdorferi
ATE543511T1 (de) Attenuierte lebendimpfstoffe gegen pleuropneumonie bei schweinen
MX2010003220A (es) Proteinas inmunogenicas de membrana exterior derivada de genoma de leptospira y composiciones y metodos basados en las mismas.
Rudakova et al. Penyevskaya NA Genospecies Diversity of Borrelia in Ixodes Ticks of the West Siberia
WO2007098717A3 (fr) Antigènes vaccinaux chimères utilisés contre le virus de la peste porcine classique
WO2006046017A8 (fr) Vaccin et acides nucleiques
BRPI0921371A2 (pt) Células-tronco para uso terapêutico que são derivados de monócito humano, e método para induzir as mesmas.
EA201491668A1 (ru) Вакцины и способы для лечения болезни лайма у собак